Keywords
musculocutaneous gastrocnemius flap - medial sural artery perforator gastrocnemius
flap - GM-MSAP - knee reconstruction - upper leg soft tissue reconstruction
Introduction
The coverage of the knee region represents a challenge for the plastic surgeon. Soft
tissue defects can expose critical structures such as joint, bone, or tendon. The
situation becomes even more complex when foreign material is present with dramatic
consequences in terms of postoperative infection and implant contamination.[1]
The reconstruction should aim to preserve the joint function and mobility, while being
solid and prevent exposure recurrence. Various surgical techniques have been described
so far to address this complex scenario, including local flaps, pedicled flaps, and
free flaps.[2]
[3]
The gastrocnemius muscle (GM) is considered the workhorse flap to reconstruct soft
tissue defects in the knee area, with proven efficacy in both posttraumatic injuries
and implant salvage.[4]
[5] The solid vascularity of the flap can guarantee an efficient antibiotic deliverance
at the injured site while the ease of harvest and the reliable surgical anatomy do
not require microsurgical expertise and is the base of its extensive use.[6]
However, some limitations should be acknowledged: potential hypotrophy of the muscle
component, limited vascularization at its distal region with difficulty to reach defects
superolateral to the patella, necessity of skin grafting over the transposed muscle
with postoperative immobilization to facilitate healing.
Last decades advancement in surgical anatomy knowledge has permitted to describe a
wide number of fasciocutaneous flaps option based on perforators vessels. The musculocutaneous
gastrocnemius flap, described in the early 70s by McCraw et al, has been recently
rediscovered for knee reconstruction, with a new knowledge on skin perforator harvest
possibilities (deriving from the sural artery system).[7]
[8] Such enhanced tailoring possibilities can expand flap potential for reconstruction,
fully exploiting both muscle and skin components.[9]
[10]
This study investigates knee reconstructions using chimeric gastrocnemius musculocutaneous–medial
sural artery perforator (GM-MSAP) flaps in complex knee reconstruction where simple
GM flap seemed insufficient, including recurring arthroplasty infections and extended
sarcoma or traumatic defects. Outcomes and complications have been critically analyzed,
together with surgical technique and planning.
Methods
Prospectively maintained databases of patients treated at three University Hospitals
from 2018 until 2021 were retrospectively searched for adult patients with knee or
upper leg defects and soft tissue reconstruction (STR). Besides oncological cases
(e.g., sarcoma resections), the majority of patients requiring STR of the knee were
patients with infected total knee joint arthroplasties (TKA) or fracture-related infections.[11]
[12]
Only patients who underwent STR with a pedicled, chimeric GM-MSAP or lateral sural
artery perforator (GM-LSAP) flap were included in this study. The patient's demographic
data and comorbidities as defined by the Charlson Comorbidity Index were recorded.
Informed consent was obtained from all patients, including approval for photographic\video
documentation. Ethical institutional approval was granted: CER-VD 2022-00434
Surgical Timing
In the oncological cases, the resection was followed by negative pressure dressing,
with STR performed after confirmation of histopathological clean margins (generally
after 7–10 d).
In infected TKAs or fracture-related infections, the duration of infection and the
causing microorganism dictated the treatment concept (one- vs. two-stage procedure).
Despite the stages, in patients of all three institutions STR was generally performed
as early as possible. In patients who underwent a one-stage procedure the STR was
performed directly after the debridement, antibiotics, and implant retention or after
the implant exchange procedure. For patients who underwent a two-stage procedure,
flap STR was performed directly after implant removal and spacer implantation during
the first of the two stages. The rationale for this relied on the following arguments:
first, early surgery maximizes the time for the soft tissue to heal and integrate.
Furthermore, a well-vascularized reconstructed tissue can act as a vehicle for the
transport of antimicrobial agents to the site of infection. However, this was not
always possible as patients were often referred after first stage treatment.
Outcome Analysis
The primary outcome was the successful STR. The first outpatient follow-up investigation
was performed 3 weeks after STR. This was followed by 6 weeks, 3 months, and 6 months
controls. Decisions on intravenous antibiotic treatment discontinuation were always
multidisciplinary including the orthopaedics and the infectious medicine team. Flap
reraise for second stage procedures were generally performed 6 to 8 weeks after debridement
and cement spacer placement. In patients who underwent a two-stage procedure, further
follow-ups were scheduled after reraising and reinsetting the flap during second stage.
Successful STR was defined by the presence of an intact and dry soft tissue envelope.
The secondary outcome was related to flap complications. Complications were listed
as major and minor, according to previous literature.[13] Major complications were considered full or partial flap necrosis (at least ⅓ of
the flap, necessitating new flap procedures), whereas minor complications were considered
partial flap necrosis (less than ⅓ of the flap, and maintained vascularization allowing
STSG). Early complications were defined as complications occurring within 6 weeks
after flap surgery (first or second stage). Late complications were defined as complications
arising between 6 weeks and up to 3 years.
Surgical Technique
Acoustic Doppler ultrasound was used as a starting point for preoperatively localizing
reasonable perforators overlying the head of the GM. A line was drawn from the midpoint
of the popliteal crease along the medial leg to the apex of the medial malleolus.
A major perforator was usually found within a semicircle with a 2 to 3 cm radius,
centered distal to a point along this line 8 cm from the popliteal crease. A second,
more significant perforator was normally found more distally, within a circle with
a radius of 2 to 3 cm centered on this same line 15 cm from the popliteal crease.
The axis of the flap was oriented in a longitudinal direction paralleling the long
bones of the leg, to capture adjacent perforasomes.[14]
Loupe magnification was used for flap harvest. The incision started at midcalf, 2 cm
behind the posterior border of the tibia on the medial aspect of the leg, and curved
proximally in direction of the popliteal fossa. After opening the deep fascia, a subfascial
dissection allowed fast visualization of perforators to the skin paddle, which were
tested in terms of size and pulsatility. Intramuscular dissection of the chosen perforator
was performed if needed to reduce the risk of perforator kinking or torsion after
flap transposition ([Fig. 1]). The skin incision around the skin paddle was then completed and the skin paddle
was secured to the underlying muscle to avoid shear forces on the perforators during
the muscle harvest.
Fig. 1 Patient no. 4 sustained a high energy trauma with Gustillo IIIA tibial fracture.
The late infection osteosynthesis material required an extensive soft tissue debridement
(A). a chimeric gastrocnemius MSAP was used for the soft tissue coverage (B). The soft tissue reconstruction at the end of the surgery (C) and at 6 months follow-up (D).
Once the flap was harvested and rotated into the defect. In our experience, once the
gastrocnemius turned medially the skin paddle will be further turned between 40 and
90 degrees, depending on the size and location of the defect.
Donor site was closed directly or skin grafted when the skin paddle was exceeding
7 cm in width ([Fig. 2]).
Fig. 2 Patient no. 9 sustained an infection of a total knee prosthesis (TKA) (A). A two-stage surgical procedure was performed including extensive soft tissue debridement,
TKA exchange with cemented spacer and soft tissue reconstruction using a chimeric
gastrocnemius-MSAP (B), the skin flap was rotated to the defect with an angle of 45 degrees (C). Follow-up at 2 months (D).
Postoperative Rehabilitation and Physiotherapy Protocols
Postoperatively, patients followed a protocol of 3 days in bed without cast immobilization.
Orthostatic position was progressively achieved from day 3 to 7, associated with class
II compression garments, and progressive knee joint mobilization (0–45 degrees from
day 3–7). In patients with framework and nonconsolidated fractures, weight-bearing
was progressively introduced according to orthopaedics, whereas patients with TKA
were weight-bearing at 2 weeks with full flexion mobilization according to pain and
under physiotherapy supervision.
Results
During the study period, 21 patients (9 females) were included. Of these, 12 patients
needed soft tissue reconstruction over an infected TKA, 4 over infected hardware of
the lower leg, and 5 after sarcoma resection. Demographics and comorbidities are outlined
in [Table 1].
Table 1
Patients data and characteristics
Pt. no.
|
Age/sex
|
BMI
|
Smoke
|
Diabetes
|
ASA score
|
Ethiology
|
Localization
|
Flap
|
Defect size (cm2)
|
Skin paddle size (cm2)
|
OP time (min)
|
FU (m)
|
1
|
72/M
|
25
|
N
|
Y
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
80
|
100
|
135
|
30
|
2
|
64/M
|
28
|
N
|
N
|
3
|
Infection OM
|
Tibia
|
GM-MSAP
|
50
|
74
|
141
|
26
|
3
|
49/F
|
23
|
Y
|
Y
|
2
|
Infected TKA
|
Knee
|
GM-MSAP
|
45
|
60
|
200
|
25
|
4
|
63/M
|
20
|
N
|
N
|
1
|
Infection OM
|
Tibia
|
GM-MSAP
|
60
|
120
|
120
|
20
|
5
|
48/F
|
23
|
N
|
N
|
1
|
Infection OM
|
Tibia
|
GM-MSAP
|
48
|
70
|
180
|
19
|
6
|
62/M
|
29
|
N
|
Y
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
35
|
70
|
330
|
7
|
7
|
55/M
|
27
|
Y
|
N
|
2
|
Infected TKA
|
Knee
|
GM-MSAP
|
48
|
60
|
150
|
7
|
8
|
42/M
|
27
|
Y
|
N
|
2
|
Sarcoma resection
|
Knee
|
GM-MSAP
|
200
|
180
|
190
|
26
|
9
|
88/F
|
25
|
N
|
N
|
2
|
Infected TKA
|
Tibia
|
GM-LSAP
|
15
|
50
|
160
|
15
|
10
|
85/F
|
35
|
N
|
N
|
3
|
Infected TKA
|
Tibia
|
GM-MSAP
|
36
|
50
|
145
|
20
|
11
|
80/M
|
31
|
N
|
N
|
2
|
Infected TKA
|
Tibia
|
GM-MSAP
|
100
|
129
|
210
|
25
|
12
|
76/F
|
28
|
N
|
N
|
3
|
Infected TKA
|
Tibia
|
GM-MSAP
|
70
|
90
|
240
|
18
|
13
|
25/F
|
19
|
N
|
N
|
1
|
Sarcoma resection
|
Knee
|
GM-LSAP
|
50
|
80
|
120
|
22
|
14
|
76/M
|
21
|
N
|
N
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
15
|
20
|
211
|
12
|
15
|
50/F
|
31
|
N
|
N
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
30
|
60
|
200
|
27
|
16
|
61/M
|
31
|
N
|
N
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
54
|
60
|
279
|
30
|
17
|
27/F
|
34
|
N
|
N
|
3
|
Infection OM
|
Tibia
|
GM-MSAP
|
140
|
100
|
235
|
15
|
18
|
78/F
|
31
|
N
|
N
|
3
|
Infected TKA
|
Knee
|
GM-MSAP
|
9
|
55
|
245
|
7
|
19
|
35/M
|
25
|
N
|
N
|
2
|
Sarcoma resection
|
Knee
|
GM-MSAP
|
63
|
80
|
150
|
9
|
20
|
29/M
|
25
|
N
|
N
|
2
|
Sarcoma resection
|
Knee
|
GM-MSAP
|
180
|
140
|
150
|
15
|
21
|
42/M
|
25
|
N
|
N
|
2
|
Sarcoma resection
|
Knee
|
GM-MSAP
|
140
|
130
|
130
|
18
|
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; F,
female; GM-LSAP, chimeric gastrocnemius musculocutaneous–lateral sural artery perforator
flap; GM-MSAP, chimeric gastrocnemius musculocutaneous–medial sural artery perforator
flap; M, male; N, no; OM, osteosynthesis material; Pt, patient; TKA, total knee arthroplasty;
Y, yes.
Orthopaedic Patients
The average age at surgery was 64 years old (range: 27–88).
One- and two-stage procedures were equally distributed in the group (8 patients each).
Defect size following the debridement was 52 cm2 on average (range: 9–140), whereas the mean size of the skin paddle was 73 cm2 (range: 20–129). A chimeric musculocutaneous GM-MSAP was used in 15 patients, whereas
in 1 patient an LSAP was used. The donor site was closed primarily in 7 patients,
whereas in the remaining 9 a skin graft was necessary. The mean follow-up was 18 months.
Flap reraise/readvancement was necessary in 11 patients due either to a recurrent
infection of the material (5 cases) or a planned two-stage procedure (6 cases; [Table 2]).
Table 2
Flaps-related characteristics
Pt no.
|
Ortho strategy/oncology
|
Type of framework
|
Donor site closure
|
Flap complications
|
Persistent infection
|
Need for reraise
|
Successful reraise
|
Further plastic surgery
|
1
|
I Stage
|
TKA
|
STSG
|
None
|
N
|
N
|
N/A
|
N
|
2
|
I Stage
|
OM
|
Direct
|
None
|
Y
|
Y
|
Y
|
N
|
3
|
I Stage
|
TKA
|
STSG
|
None
|
N
|
Y
|
Y
|
N
|
4
|
II Stage
|
OM
|
STSG
|
None
|
N
|
N
|
N/A
|
N
|
5
|
I Stage
|
TKA
|
Direct
|
None
|
N
|
N
|
N/A
|
N
|
6
|
II Stage
|
Spacer
|
Direct
|
None
|
N
|
Y
|
Y
|
N
|
7
|
I Stage
|
Spacer
|
STSG
|
Wound dehiscence
|
N
|
Y
|
Y
|
N
|
8
|
Oncology
|
N/A
|
STSG
|
Partial flap necrosis
|
N/A
|
N/A
|
N/A
|
Lateral GM
|
9
|
II Stage
|
Spacer
|
STSG
|
None
|
N
|
Y
|
Y
|
N
|
10
|
II Stage
|
TKA
|
Direct
|
None
|
N
|
Y
|
Y
|
N
|
11
|
II Stage
|
Spacer
|
Direct
|
None
|
N
|
Y
|
Y
|
N
|
12
|
I Stage
|
TKA
|
STSG
|
None
|
Y
|
Y
|
Y
|
N
|
13
|
Oncology
|
N/A
|
Direct
|
None
|
N/A
|
N/A
|
N/A
|
N
|
14
|
II Stage
|
Spacer
|
STSG
|
None
|
N
|
Y
|
Y
|
N
|
15
|
I Stage
|
TKA
|
Direct
|
None
|
Y
|
Y
|
Y
|
N
|
16
|
I Stage
|
TKA
|
STSG
|
None
|
Y
|
N
|
N/A
|
N
|
17
|
I Stage
|
OM
|
STSG
|
Superficial skin necrosis
|
N
|
N
|
N/A
|
N
|
18
|
II Stage
|
Spacer
|
Direct
|
None
|
Y
|
Y
|
Y
|
N
|
19
|
Oncology
|
N/A
|
Direct
|
None
|
N/A
|
N/A
|
N/A
|
N
|
20
|
Oncology
|
N/A
|
STSG
|
None
|
N/A
|
N/A
|
N/A
|
N
|
21
|
Oncology
|
N/A
|
STSG
|
None
|
N/A
|
N/A
|
N/A
|
N
|
Abbreviations: GM, gastrocnemius muscle; N/A, not applicable; OM, osteosynthesis material;
N, no; STSG, split thickness skin graft; TKA, total knee arthroplasty; Y, yes.
Flap reraise associated to further implant exchange or extensive debridement/washout
was successful in all cases, without need for any further flap procedure. Limb salvage
was achieved in all cases.
Among complications, we recorded 1 case of flap wound dehiscence and 1 case of distal
flap necrosis which were managed successfully with conservative treatment without
need of further procedures. One case of donor site infection was recorded following
skin graft and was addressed with a superficial debridement and a new STSG.
Oncological Patients
The flap coverage was performed following the confirmation of the pathological margins
of resection. Defects ranged from 50 to 200 cm2 (average: 126) with a skin paddle average of 122 cm2 (range: 80–180). A GM-MSAP was used in 4 out of 5 cases and a GM-LSAP was used in
the remaining. The donor site was closed primarily in 2 cases, whereas in 3 patients
a skin graft was used. On average, the follow-up was of 18 months.
Among complications, a distal necrosis of the MSAP skin paddle in patient nr. 8 led
to reexposure of bone element around the knee and a muscular lateral gastrocnemius
was necessary to ensure stable coverage ([Table 3]).
Table 3
Comparison between orthopaedic and oncological patients
|
Orthopaedic Pt
|
Oncological Pt
|
Number of patients
|
16
|
5
|
Mean age (y)
|
64
|
34
|
MSAP/LSAP
|
15/1
|
4/1
|
Mean defect size (cm2)
|
52
|
126
|
Mean skin paddle size (cm2)
|
73
|
122
|
Mean operative time (min)
|
198
|
228
|
Mean follow-up (mo)
|
18
|
18
|
Major complications
|
0
|
1
|
Minor complications
|
3
|
0
|
Abbreviations: MSAP/LSAP, medial sural artery perforator/lateral sural artery perforator;
Pt, patient.
Discussion
The lack of soft tissue availability and skin redundancy at the knee level represent
a well-known issue and makes local options relatively limited in terms of size and
flap component. Despite evolution in prosthetic surgery and microbiological innovations,
persistent infection and multiple reoperations are often necessary in case of implant
infection, arming the viability of the local soft tissue around the knee.[15]
Muscle flap coverage is often required in such situation either as a prophylactic
treatment or during revision surgery. Despite being a workhorse flap in such context,
GM is sometimes insufficient to reach superolateral and supra patellar defects, being
sometimes particularly narrow or tendinous in its distal part, making coverage less
stable. Moreover, the need to skin grafting makes postoperative immobilization and
healing longer.[16]
[17]
[18] Even if closer to the knee apex, distally based muscle flaps are either insufficient
(sartorius) or retain unacceptable donor site morbidity (e.g., vastus lateralis).[18] Fasciocutaneous flaps alternatives from the knee area have been proposed, such as
medial or lateral superior genicular artery perforator flaps or saphenous flaps.[17] However, these flaps are generally reduced in size and can reach anterior tibial
tuberosity with difficulty. Reverse-flow anterolateral thigh flaps has been proposed
as effective solution for superior and superolateral defects, but the risk of venous
congestion should be considered as it may potentially impair the reconstruction, especially
if framework material or TKA is present.[2]
The MSAP flap,[19] despite being an elegant solution for superficial knee resurfacing, has some relevant
disadvantages in arthroplasty procedures, such as difficult harvesting with perforator
intramuscular dissection, longer operative time,[16] and, mostly, the lack of a reliable muscle component to fill dead space and guarantee
adequate vascular perfusion around the knee implant.
Although musculocutaneous gastrocnemius has been described long time ago,[7] literature shows how it did have limited success, probably due to its bulkiness
and inset difficulties when harvesting the whole skin over the calf area.
However, composite principles and perforator/propeller flaps recently opened new tailoring
possibilities in complex knee reconstructions. Indeed, composite flaps can incorporate
multiple tissue types (e.g., muscle and skin), which are potentially connected only
by branching or perforating vessels. A chimeric GM-MSAP flap can therefore serve for
the double aim of filling a deep defect, while at the same time addressing skin shortage
with the fasciocutaneous component.[20]
[21]
[22]
As mentioned, the skin paddle component allows to reach cranial and superolateral
defects which are generally out of the reach of a simple GM flap. This potential is
further enhanced in case of more distal perforators entering the skin and eccentric
placement of the skin paddle in relation to the perforator. This chimeric solution
is particularly fit in those defects involving the tibial tuberosity (covered by the
muscle) and the patella, covered by the skin paddle rotated in a propeller fashion.[23]
In our experience, this chimeric flap has revealed to be particularly powerful when
addressing implant-associated defects. In the first step of two-stage TKA revisions,
the presence of the skin paddle enables a wider coverage, with increased quantity
of antibiotic cement to be delivered. In the second step, the skin paddle allows for
more elasticity over the knee and an easier access to the ortho team, minimizing the
risks of suture tension and breakdown.
It should be considered that TKA revisions are extremely complex as they often imply
multiple reinterventions on the same patient, with persistent infectious risk, despite
the surgical strategy chosen (one vs. two stages). The presence of a solid skin paddle
and therefore acquired skin availability and laxity enables the surgeon multiple flap
reraises when needed.
It has been reported that up to 0.5% of patients with TKA will finally return to theater
after early wound healing complications.[1] Among these, more than 50% incur into a deep wound infection after TKA. This translates
into a percentage of over 5% of required supplementary major additional surgery in
the long term.[23]
When dealing with relevant oncological defects around the knee, both muscle and skin
components could be used to resurface the whole area without the need of a free flap.
Despite expanding the GM coverage size possibilities, this chimeric modification does
not replace the role of free flaps, as sovra-dimentioned skin paddles may incur in
partial necrosis, as happened in patient nr. 8.
Mayoly et al described the use of the conventional GM flap in a series of 16 soft
tissue knee reconstruction, leaving the cutaneous portion attached to the underlying
muscle.[17] Their results are similar to those experienced in this study; however, our surgical
technique involves the individualization and dissection of the most distal suitable
perforator to allow us to propeller the skin paddle over the muscle and gain as much
arc of rotation as possible and increase the surface of the flap.
Importantly, it needs to be noticed that in roughly 10% of cases, MSA perforators
are not eligible for a safe perforator–propeller skin flap harvest.[24] In our series, when basing a relevant skin paddle on a small-sized perforator we
incurred in a superficial skin paddle necrosis, which may result in secondary flap
procedures if defects to be covered are particularly extended. We believe that the
surgical procedure should always start with the exploration of the available perforator
through an anterior approach: in case of lack of suitable perforators, a standard
GM-only flap can be easily performed as backup solution without adding further scars.
Importantly, besides perforator size, perforator's position should be carefully evaluated.
Basing the skin paddle MSAP on perforators too proximal to the gastrocnemius pivot
point will reduce the potential flap length or require a distal extension of the skin
paddle with the potential risk of vascular insufficiency.[25]
According to our experience the microsurgical skill level required for the chimeric
MSAP flap harvest is relatively low. The perforator intramuscular dissection is usually
limited and the plane between the subcutaneous tissue and the deep fascia (where the
perforators are encountered) is easily dissected bluntly, minimizing the risk of vascular
damage.
On the other hand, the learning curve is steeper when it comes to flap inset at the
recipient site, especially in complicated knees with multiple previous surgical accesses
and scars. Flap design need to be accurately planned on perforator position, specifically
when a skin bridge is present between the flap tibial harvesting incision and the
defect. When designing the flap, the distance between the flap pedicle pivot point
(in the popliteal fossa) and the proximal part of the skin paddle will generally correspond
to the width of the cutaneous bridge. This will reduce flap bulk under the bridge
and will allow to place the skin component only where needed.
We acknowledge the retrospective nature of this study, the relatively low number of
cases and the lack of a comparative cohort of patients (e.g., GM-only flap).
Nevertheless, this study represents to our knowledge the largest series in literature
using a chimeric musculocutaneous GM-MSAP/LSAP propeller–perforator flap, with a relevant
number of patients presenting knee defects associated to osteosynthesis material and
TKA. This allowed evaluating GM-MSAP flaps performances during a long-term follow
up, not only in terms of simple quality of coverage, but more importantly in terms
of facility of flap reraise in case of repeated surgeries over time.
This specific flap tool translates in a critical advantage in orthoplastic surgery
of the knee and when dealing with repeatedly infected TKA or frameworks requiring
coverage.